KRAS and neoplasm: In this study, we focused on an LGSOC with a KRAS mutation from which several well-characterized patient-derived tumor models are established, generated from peritoneal metastases, including a patient-derived cell line, mouse PDX and long-term 3D scaffold [20,21].